News Center

I-Mab Presents Positive Uliledlimab Pharmacokinetics Data at 2024 World Conference on Lung Cancer

- Pharmacokinetic/pharmacodynamic (PK/PD) modeling data from three Phase 1 studies providing dosing support for upcoming clinical trials

09-11 I-Mab Biopharma

Cooperation urged to grow innovation

SHANGHAI,Sept. 10,2024-- A news report fromenglish.shanghai.gov.cn Shanghai forum aims to attract more financial capital to eastern metropolis

09-11 english.shanghai.gov.cn

Vertilas InP VCSEL product portfolio presented at CIOE 2024 in Shenzhen, China

SHENZHEN,China,Sept. 10,2024-- Vertilas GmbH invites you to join our team at Booth 4D021+4D022 during the China International Optoelectronic Exposition (CIOE) 2024 in Shenzhen on 11-13 September 2024

09-11 Vertilas GmbH

Muon Showcases Next-Gen E-Bikes and Smart Technologies at IFA 2024, Leading the Future of Green Mobility

BERLIN,Sept. 10,2024-- The world\'s largest consumer and electronics show,IFA 2024,kicked off in Berlin on September 6th. As a pioneering brand in the electric bike sector,Muon unveiled its latest inn

09-11 Muon

Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024

GAITHERSBURG,Md.,Sept. 10,2024-- LakeShore Biopharma Co.,Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"),a global biopharmaceutical company dedicated to discovering,deve

09-11 LakeShore Biopharma Co., Ltd

Finance Meets Technology: Unlocking Future Investment at VIFS 2024

VANCOUVER,Sept. 10,2024-- In the ever-evolving global economy,challenges and opportunities coexist,leaving investors to ask: how can one stay ahead in such a dynamic market? The 2024 Vancouver Interna

09-11 FX168 Finance Group

GC Cell and PT Bifarma Adiluhung sign a licensing agreement for Immuncell-LC to expand access in Indonesia

YONGIN,South Korea,Sept. 11,2024--GC Cell,a leading innovator in cell therapy,has officially announced the execution of a landmark \'Technology Transfer and License Agreement\' with PT Bifarma Adiluh

09-11 GC Cell

Nuance Pharma completes recruitment for ENHANCE-CHINA, the phase 3 clinical trial of ensifentrine for the maintenance treatment of COPD

SHANGHAI,Sept. 11,2024-- Nuance Pharma today announced it has completed the recruitment of patients for the ENHANCE-CHINA (NCT05743075) study,after planned number of patients have been successfully en

09-11 Nuance Pharma Limited

CLOU Electronics Releases Two Versions of the 5MWh+ Energy Storage System Aqua-C2.5

ANAHEIM,Calif.,Sept. 11,2024-- The global leading energy storage system integrator,CLOU Electronics,has introduced its latest liquid-cooling energy storage system,Aqua-C2.5,during the 2024 RE+ exhibit

09-11 CLOU Electronics Co., Ltd.

Shoplazza Partners with Stripe to Revolutionize E-Commerce Payment Solutions

SINGAPORE,Sept. 11,2024--Shoplazza,a leader of e-commerce solutions,announced today a new partnership with Stripe,a financial infrastructure platform for businesses,to power Shoplazza\'s payment plat

09-11 Shoplazza